Xpeng Inc - ADR vs 22nd Century Group Inc — how do they compare? Xpeng Inc - ADR trades at $13.35 (market cap $12.96B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Xpeng Inc - ADR is far larger — about 8698× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| XPEV | XXII | |
|---|---|---|
Market Cap | $12.96B | $1.49M |
Sector | Consumer Cyclical | Technology |
52-Week High | $28.07 | $1.07K |
52-Week Low | $12.09 | $3.90 |
Enterprise Value | $15.07B | -$6.74M |
Signals from Pluang's Aura AI — not financial advice
XPeng (XPEV) trades at $13.33, down 1.52% today, with a bearish technical signal and neutral oscillators. Revenue grew to $76.72B in 2025, but net income remained negative at -$1.14B, with improving margins. Recent news highlights global expansion, including the L03 SUV launch in Munich and Robotaxi testing, while Q2 2026 deliveries of 103,295 vehicles beat expectations, signaling demand recovery.
The stock offers upside to the $17.00 analyst target but faces risks from intense EV competition and persistent losses. Investor sentiment is mixed, with 64.7% of analysts rating it Buy, yet technical trends and cash flow volatility warrant caution. Key catalysts include new model launches and international growth, but profitability remains a critical hurdle.
No Aura AI signal available yet.
Trailing returns across standard periods
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →